High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study:

Background:Tumor progression following endocrine therapy is considered to indicate resistance to endocrine drugs due to a variety of mechanisms. An insufficient dose of endocrine drugs is one of th...